SC
YARW

Shay Capital’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Shay Capital’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$962K Sell
32,205
-282
-0.9% -$8.23K 0.08% 177
2025
Q4 		$942K Buy
32,487
+22,635
+230% +$454K 0.1% 192
2025
Q3 		$165K Buy
+9,852
New +$322K 0.01% 359
2025
Q2 		– Sell
-360
Closed -$28.5K – 438
2025
Q1 		$28.5K Buy
+360
New +$44.3K ﹤0.01% 295

Other funds holding YARW

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Shay Capital's YARW Position: Q1 2026 in Review

Shay Capital reduced its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 0.87% in Q1 2026, selling an estimated $8.23K and leaving 32,205 shares worth $962K. The position accounts for 0.08% of the portfolio, ranked #177.

Shay Capital first reported a position in YARW in Q1 2025 and has held it in 4 quarters since. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Shay Capital held 32,205 shares of Yarrow Bioscience, Inc. Common Stock worth $962K as of Q1 2026.
  • Shay Capital sold 282 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $8.23K.
  • Yarrow Bioscience, Inc. Common Stock made up 0.08% of Shay Capital's portfolio in Q1 2026, its #177 holding.
  • Shay Capital first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2025 and has held it in 4 quarters since.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.